SCPH,scPharmaceuticals Inc. | Healthcare

Healthcare

SCPH

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

scPharmaceuticals Inc.SCPH

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.

The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure.

Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms.

The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device.

The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Latest News >

Bitcoin (BTC) Price Rally, Dogecoin (DOGE) Advancement, Ripple (XRP) Predictions: Bits Recap May 23

May 23, 2024

TL;DR BTCs price climbed above $71,000 due to optimism about Ethereum ETF approval, resulting in a 6% weekly and 13% monthly increase, but then retraced to $69,500. DOGEs value ascended as well, briefly surpassing $0.17 and achieving a market cap near $25 billion. Significant metrics rose, with 85% of holders in profit. XRPs price saw a slight increase with predictions...

Krystal Biotech Insider Sold Shares Worth $3,282,690, According to a Recent SEC Filing

May 23, 2024

03:49 AM EDT, 05/23/2024 (MT Newswires) -- Julian S Gangolli, Director, on May 20, 2024, sold 20,000 shares in Krystal Biotech ( KRYS ) for $3,282,690. SEC Filing: https://www.sec.gov/Archives/edgar/data/1711279/000153202324000008/xslF345X03/wk-form4_1716416222.xml Price: 172.69, Change: +3.44, Percent Change: +2.03 ...

Atlassian Insider Sold Shares Worth $1,470,592, According to a Recent SEC Filing

May 23, 2024

03:50 AM EDT, 05/23/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-Chief Executive Officer, Co-Founder, on May 21, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,470,592. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 209,871 shares of the company, with 209,871 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024004333/xslF345X03/primarydocument.xml Price: 180.00, Change:...

Atlassian Insider Sold Shares Worth $1,470,591, According to a Recent SEC Filing

May 23, 2024

03:49 AM EDT, 05/23/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-Chief Executive Officer, Co-Founder, on May 21, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,470,591. Following the Form 4 filing with the SEC, Farquhar has control over a total of 209,871 shares of the company, with 209,871 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024004332/xslF345X03/primarydocument.xml Price: 180.00, Change:...